We are live on
!
Find out more
MYOK
MyoKardia, Inc. Common Stock
MYOK
MYOK
Delisted
MYOK was delisted on the 16th of November, 2020.
71 hedge funds and large institutions have $195M invested in MyoKardia, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 31 increasing their positions, 9 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
244% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 9
82% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 11
13% more funds holding
Funds holding: 63 → 71 (+8)
16% less capital invested
Capital invested by funds: $233M → $195M (-$37.6M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
71
Holders Change
+8
Holders Change %
+12.7%
% of All Funds
1.77%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
20
Increased
31
Reduced
9
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Millennium Management
New York
|
+$7.16M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$5.11M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.73M |
| 4 |
CC
Casdin Capital
New York
|
+$1.62M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.56M |
